MAM
EVFM

Meeder Asset Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Meeder Asset Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-18
Closed -$1K – 2635
2020
Q1 		$1K Buy
+18
New +$1.44K ﹤0.01% 2275

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Meeder Asset Management's EVFM Position: Q2 2020 in Review

Meeder Asset Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2020, closing a stake of 18 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in EVFM in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 122 funds tracked by Wall St. Rank hold EVFM as of Q2 2020.

  • Meeder Asset Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 18 Evofem Biosciences, Inc. Common Stock shares in Q2 2020, an estimated $1K.
  • Meeder Asset Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
  • Meeder Asset Management's Evofem Biosciences, Inc. Common Stock position peaked at $1K in Q1 2020.
  • 122 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.